• Clinic specializing in Regeneus stem cell therapy

    Patient registry for HiQCell to provide important long-term data

    Regeneus engaged the IMRI to develop a patient registry for HiQCell. The registry will determine longterm safety and efficacy of the treatment and will monitor various clinical and functional outcomes of patients who have had HiQCell for the treatment of osteoarthritis-affected joints.

    More »

  • Stem cell therapy preparation

    Stem cells enhance cancer vaccine

    Regeneus and researchers at the Kolling Institute of Medical Research have discovered in preliminary findings that Regeneus prepared stem cells have a positive improvement on the effect of a cell-based cancer treatment vaccine.

    More »

  • Injection of the HiQCell stem cell therapy

    Stem cell therapy comes to John Flynn Private Hospital in the Gold Coast

    Regeneus has expanded its footprint from the Sydney facilities offering HiQCell and has established a new cell processing laboratory at John Flynn Private Hospital in the Gold Coast allowing Queensland patients closer access to the treatment.

    More »

  • CryoShot - an allogeneic stem cell therapy

    Off-the-shelf stem cell therapy to treat canine and equine osteoarthritis

    CryoShot is an allogeneic cell-based product derived from regenerative cells in adipose tissue including mesenchymal stem cells and adipocytes for the canine and equine markets.

    More »

  • Cryogenic cellular therapies storage

    Freezing of stem cells for osteoarthritis now available

    Regenerative medicine company, Regeneus, and cryogenic storage specialists, Cryosite Limited, have completed the development of a procedure for storing a patient's regenerative stem cells from fat.

    More »

  • Stem cell therapy specialist at work

    Regeneus validates therapeutic benefits of stem cell secretions platform

    Regeneus completed a successful trial validating the efficacy of the company's adipose (fat) derived stem cell secretion therapy using a well-established mouse model for rheumatoid arthritis.

    More »

At Regeneus, we strive to improve quality of life through cellular therapies

We develop and commercialise proprietary technologies for the preparation of autologous point-of-care and off-the-shelf cell therapies.

We do this using adipose (fat)-derived regenerative cells including mesenchymal stem cells for the treatment of musculoskeletal and other inflammatory conditions in humans and animals.

More about us »

Our Therapies

Human Health

Find your nearest HiQCell medical practitioner

Animal Health

CryoShot is an off-the-shelf stem cell therapy used for the treatment of conditions such as osteoarthritis in dogs and horses. More » about CryoShot

Find your nearest Cryoshot veterinary partner